secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED THERAPEUTICS Corp (UTHR)
CIK:        0001082554
Form:       8-K
Filed at:   2026-07-23T11:00:29+00:00
Accession:  0001104659-26-086068
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United Therapeutics appoints Victor Dzau to Board of Directors
--------------------------------------------------------------

- Board expanded to 13 members; Victor Dzau, M.D., appointed effective July 22, 2026.
- Dr. Dzau recently completed 12-year tenure as President of the National Academy of Medicine.
- Initial grant: 380 RSUs and 1,190 stock options; pro-rata grant: 350 RSUs and 1,110 options.
- No transactions exceeding $120,000 between Dr. Dzau and the company since last fiscal year.
- Dr. Dzau will not serve on any Board committee initially.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1082554/000110465926086068/0001104659-26-086068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1082554/000110465926086068/tm2620809d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-086068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer